SCHEMBL4240160

SCHEMBL4240160

Cc1cscc1CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811004 0.80
SCHEMBL6805109 0.76
SCHEMBL14498125 0.75 GABRA1 (0.37)
SCHEMBL4249004 0.74
SCHEMBL9798315 0.74
SCHEMBL11859041 0.74
SCHEMBL132375 0.74
SCHEMBL10333955 0.72
SCHEMBL129408 0.69
SCHEMBL827534 0.69 SKP2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024120505-A1 FUSED RING DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATES THEREOF, AND USE THEREOF 上海枢境生物科技有限公司 2024-06-13 WO disclosed
US-20240190888-A1 SPIRO-CONTAINING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF SHUJING BIOPHARMA CO., LTD (CN) 2024-06-13 US disclosed
EP-4317164-A1 SPIRO-CONTAINING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shujing Biopharma Co., Ltd (CN) 2024-02-07 EP disclosed
CN-116987095-A Spiro-containing derivative, preparation method and application thereof 上海枢境生物科技有限公司 2023-11-03 CN disclosed
CN-116057060-B Spiro-containing derivative, preparation method and application thereof 上海枢境生物科技有限公司 2023-08-29 CN disclosed
CN-116057060-A Spiro-containing derivative, preparation method and application thereof 上海枢境生物科技有限公司 2023-05-02 CN disclosed
WO-2022206706-A1 SPIRO-CONTAINING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海枢境生物科技有限公司 2022-10-06 WO disclosed
US-7491735-B2 Chemokine receptor binding compounds GENZYME CORPORATION (US) 2009-02-17 US disclosed
EP-1708703-A4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC (CA) 2008-04-09 EP disclosed
EP-1708703-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2006-10-11 EP disclosed
US-20050277670-A1 Chemokine receptor binding compounds ANORMED INC. 2005-12-15 US disclosed
WO-2005059107-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2005-06-30 WO disclosed